Avient CFO Di Salvo reports initial holdings
Avient Corp SVP and CFO Giuseppe Di Salvo filed an initial ownership report showing existing equity interests, without reporting any new purchases or sales.
Rhea-AI Filing Summary
Avient Corp SVP and CFO Giuseppe Di Salvo filed an initial ownership report showing existing equity interests, without reporting any new purchases or sales. He indirectly holds 18,300.401 shares of Avient common stock through a Supplemental Plan as of June 1, 2026.
He also holds several Stock Appreciation Rights on Avient common stock with exercise prices between $31.48 and $52.64 per share and expiration dates from 2029 through 2034. In addition, he has multiple restricted stock unit awards that each represent a contingent right to receive one share of Avient common stock, vesting between 2027 and 2029 under their grant agreements.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Di Salvo Giuseppe
Role
SVP, Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 5,723 contracts (Direct);
Stock Appreciation Rights — 25,320 contracts (Direct);
Common Stock — 18,300.401 shares (Indirect, Supplemental Plan)
Footnotes (11)
- F1. The information in this report is based on a plan statement as of June 1, 2026.
- F2. The restricted stock units vest 3 years from the date of grant on February 22, 2027.
- F3. Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
- F4. The restricted stock units vest in substantially equal installments on each of February 19, 2027 and February 19, 2028, unless earlier vested or terminated pursuant to the terms of the grant agreement.
- F5. The restricted stock units vest in substantially equal installments on each of February 20, 2027, February 20, 2028 and February 20, 2029, unless earlier vested or terminated pursuant to the terms of the grant agreement.
- F6. Stock appreciation rights ("SARs") become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
- F7. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.
- F8. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years
- F9. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.
- F10. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.
- F11. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $39.27 per share and no more than one-third of the grant can vest per year during the first three years.
Key Figures
Indirect common stock: 18,300.401 shares
SAR grant 1: 5,250 underlying shares at $39.27
SAR grant 2: 5,000 underlying shares at $42.93
+5 more
8 metrics
Indirect common stock
18,300.401 shares
Indirectly held through Supplemental Plan as of June 1, 2026
SAR grant 1
5,250 underlying shares at $39.27
Stock Appreciation Rights, expiration February 22, 2034
SAR grant 2
5,000 underlying shares at $42.93
Stock Appreciation Rights, expiration February 17, 2033
SAR grant 3
4,250 underlying shares at $52.64
Stock Appreciation Rights, expiration February 14, 2032
SAR grant 4
5,470 underlying shares at $42.27
Stock Appreciation Rights, expiration February 8, 2031
RSU grant 1
2,783 units
Restricted Stock Units vesting three years from grant on February 22, 2027
RSU grant 2
1,179 units
Restricted Stock Units vesting in equal installments on February 19, 2027 and 2028
RSU grant 3
1,761 units
Restricted Stock Units vesting in equal installments 2027–2029 on February 20 each year
Key Terms
Supplemental Plan, Restricted Stock Units, contingent right, Stock Appreciation Rights, +1 more
5 terms
Supplemental Plan financial
"The information in this report is based on a plan statement as of June 1, 2026."
A supplemental plan is an additional agreement or policy that sits on top of a company’s main benefit, retirement or operational plan to provide extra coverage, payments or rules. Think of it like adding a warranty to a purchase: it can protect employees or cover gaps the base plan doesn’t, but it also creates extra future costs and obligations that investors should watch because they affect a company’s payroll expenses, cash needs and long-term liabilities.
Restricted Stock Units financial
"The restricted stock units vest 3 years from the date of grant on February 22, 2027."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of Avient common stock."
Stock Appreciation Rights financial
"Stock appreciation rights ("SARs") become exercisable and vest only upon the achievement of both price and time requirements."
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
stock appreciation financial
"Each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Giuseppe Di Salvo’s Form 3 filing for AVNT report?
The Form 3 for Avient (AVNT) reports Giuseppe Di Salvo’s existing equity holdings as a new reporting insider. It details indirect common stock held via a Supplemental Plan plus multiple stock appreciation rights and restricted stock units, but shows no new share purchases or sales.
What stock appreciation rights does the Avient (AVNT) CFO hold?
The Avient CFO holds several Stock Appreciation Rights on common stock with exercise prices from $31.48 to $52.64 per share. These SARs have expiration dates between 2029 and 2034 and vest only after meeting both time-based and stock price appreciation requirements described in the footnotes.
How do Giuseppe Di Salvo’s restricted stock units in AVNT vest?
His restricted stock units each convert into one Avient common share upon vesting. One grant vests three years from grant on February 22, 2027, while others vest in substantially equal installments between February 2027 and February 2029, subject to their grant agreements.
Does the AVNT Form 3 show any insider buying or selling activity?
The Form 3 for Avient does not show insider buying or selling activity by Giuseppe Di Salvo. It classifies the entries as holdings, providing an initial snapshot of his existing common stock, stock appreciation rights, and restricted stock units, rather than recording new trades.
What role does Giuseppe Di Salvo hold at Avient (AVNT)?
Giuseppe Di Salvo is identified as Avient’s Senior Vice President and Chief Financial Officer. As an executive officer, he must report his equity interests and subsequent transactions in Avient securities, starting with this initial Form 3 ownership statement filed with the SEC.
AI-generated analysis. How Rhea-AI works. Not financial advice.
